Basic Information
LncRNA/CircRNA Name | AKR7L |
Synonyms | AKR7L, AFAR3, AFB1-AR 3, AFB1-AR3, AKR7A4 |
Region | GRCh38_1:19265982-19274194 |
Ensemble | ENSG00000211454 |
Refseq | NA |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | Drug | |||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | gastric cancer |
ICD-0-3 | C16 |
Methods | Microarray, qPCR, RNAi etc. |
Sample | gastric cancer tissues |
Expression Pattern | down-regulated |
Function Description | LncRNA M59227 and 3 mRNAs, PLK1, PTTG1 and VCAN, were overexpressed in GC. In contrast, the expression of 4 lncRNAs, LOC150622, AKR7 L, DQ192290 and BC040587, and 2 mRNAs, DRD5 and GDF5, were downregulated in GC.The results indicated that TUSC7 is a p53-regulated tumour suppressor that acts in part by repressing miR-23b and that TUSC7 may be a key regulatory hub in GC. |
Pubmed ID | 25765901 |
Year | 2015 |
Title | Reciprocal repression between TUSC7 and miR-23b in gastric cancer. |
External Links
Links for AKR7L | GenBank HGNC NONCODE |
Links for gastric cancer | OMIM COSMIC |